Table 2. Summary statistics for the eligible UK biobank cohort.
Unaffected Total 401,006 | Affected (incident cases) Total 2,992 | |
---|---|---|
N (%) | N (%) | |
Age at cohort entry (years) | ||
40–49 | 88,648 (22.11) | 198 (6.62) |
50–59 | 133,056 (33.18) | 800 (26.74) |
60–69 | 179,302 (44.71) | 1,994 (66.64) |
Age when diagnosed with colorectal cancer (years) | ||
40–49 | – | 79 (2.64) |
50–59 | – | 496 (16.58) |
60–69 | – | 1,647 (55.05) |
70–79 | – | 770 (25.74) |
Gender | ||
Female | 217,501 (54.24) | 1,275 (42.61) |
Male | 183,505 (45.76) | 1,717 (57.39) |
Number of first-degree relatives diagnosed with colorectal cancer | ||
0 | 356,437 (88.89) | 2,544 (85.03) |
1 | 42,129 (10.51) | 412 (13.77) |
2+ | 2440 (0.61) | 36 (1.20) |
Mean (SD) median | Mean (SD) median | |
Full lifetime risk: combined model | 0.068 (0.041) 0.057 | 0.080 (0.050) 0.067 |
10-year risk: combined model | 0.011 (0.009) 0.008 | 0.016 (0.013) 0.013 |
Relative risk: PRS | 0.999 (0.574) 0.848 | 1.112 (0.657) 0.934 |